Jubilant Pharmova Limited (BOM:530019)
India · Delayed Price · Currency is INR 944.75
+5.85 (0.62%)
At close: Feb 12, 2026
Jubilant Pharmova Market Cap
Jubilant Pharmova has a market cap or net worth of 149.65 billion as of February 13, 2026. Its market cap has increased by 2.41% in one year.
Market Cap
149.65B
Enterprise Value
172.04B
Revenue
79.18B
Ranking
n/a
PE Ratio
34.68
Stock Price
944.75
Market Cap Chart
Since May 30, 2000, Jubilant Pharmova's market cap has increased from 406.73M to 149.65B, an increase of 36,692.21%. That is a compound annual growth rate of 25.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 149.65B | -12.10% |
| Dec 31, 2025 | 170.24B | -2.67% |
| Dec 31, 2024 | 174.91B | 101.48% |
| Dec 29, 2023 | 86.81B | 45.28% |
| Dec 30, 2022 | 59.75B | -36.05% |
| Dec 31, 2021 | 93.44B | -30.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pharmaceuticals | 457.53B |
| J. B. Chemicals & Pharmaceuticals | 305.76B |
| AstraZeneca Pharma India | 226.77B |
| Granules India | 140.43B |
| Caplin Point Laboratories | 132.23B |
| Rubicon Research | 128.62B |
| CORONA Remedies | 98.72B |
| Viyash Scientific | 97.40B |